Your body is adjusting to a fundamentally different pace of digestion, and that adjustment takes time
Theres growing evidence that GLP1s may also have direct effects on liver fat metabolism, although this remains under investigation
Key takeaways: GLP-1 receptor agonists (e.g., semaglutide, liraglutide, tirzapeptide) are now approved for weight loss for overweight teens and adults
Not everyone will qualify for GLP-1 therapy
Polyzos, S
Preliminary data from a phase 1b extension study (NCT05292911) involving 64 individuals with MRI-PDFF 10% and BMI 28 kg/m 2 demonstrated that 50%, 44%, and 60% of participants presenting baseline alanine aminotransferase (ALT) 30 IU/L reached combined MRI-PDFF reduction 30% and ALT reduction 17 IU/L at pemvidutide doses of 1.2, 1.8, and 2.4 mg, respectively, vs